NeoGenomics, Inc.NEONASDAQ

Revenue (LTM)

$727M

+10.1% YoY

Net Income (LTM)

$-108M

-37.2% YoY

Free Cash Flow

$-22M

Revenue CAGR (5Y)

+10.4%

Marginsimproving

FCF($0.0B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	484	510↑5.2%	592↑16.1%	661↑11.6%	727↑10.1%
Gross Profit	187	188↑0.4%	245↑30.2%	290↑18.6%	283↓2.6%
Operating Income	-119	-158↓32.7%	-108↑31.6%	-92↑14.5%	-66↑28.3%
Net Income	-8	-144↓1628.2%	-88↑39.0%	-79↑10.5%	-108↓37.2%
EBITDA	-65	-82↓25.9%	-18↑78.6%	-2↑91.4%	2↑215.5%
EPS Diluted	-0.35	-5.80↓1557.1%	-3.50↑39.7%	-3.10↑11.4%	-4.20↓35.5%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	317	263↓16.9%	342↑30.1%	367↑7.2%	160↓56.5%
Total Current Assets	682	605↓11.2%	597↓1.4%	596↓0.1%	376↓36.9%
Total Assets	1,870	1,740↓6.9%	1,681↓3.4%	1,638↓2.6%	1,360↓17.0%
Total Current Liabilities	87	90↑3.1%	96↑7.1%	301↑212.8%	88↓70.7%
Total Liabilities	762	742↓2.6%	740↓0.3%	736↓0.5%	523↓28.9%
Total Equity	1,108	998↓9.9%	942↓5.7%	902↓4.2%	837↓7.3%
Total Debt	613	611↓0.3%	612↑0.1%	605↓1.0%	472↓22.0%
Net Debt	296	348↑17.5%	269↓22.6%	238↓11.5%	313↑31.2%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-27	-66↓147.0%	-2↑97.0%	7↑459.6%	5↓25.5%
Capital Expenditure	-64	-31↑51.8%	-29↑6.9%	-41↓42.8%	-27↑34.2%
Free Cash Flow	-91	-97↓6.6%	-31↑68.3%	-34↓10.9%	-22↑36.0%
Stock-Based Comp	22	25↑9.9%	25↓0.2%	33↑35.6%	41↑23.7%
Net Change in Cash	66	-54↓181.0%	79↑247.8%	25↓69.1%	-207↓945.7%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance